Serial Analysis of 3D H-1 MRSI for Patients With Newly Diagnosed GBM Treated With Combination Therapy That Includes Bevacizumab

Journal of Neuro-Oncology - Netherlands
doi 10.1007/s11060-016-2229-3

Related search